ATE444375T1 - Verfahren zum screening einer zur beschleunigung oder hemmung von apoptose fähigen verbindung, apoptosebeschleuniger und apoptosehemmer - Google Patents

Verfahren zum screening einer zur beschleunigung oder hemmung von apoptose fähigen verbindung, apoptosebeschleuniger und apoptosehemmer

Info

Publication number
ATE444375T1
ATE444375T1 AT05727106T AT05727106T ATE444375T1 AT E444375 T1 ATE444375 T1 AT E444375T1 AT 05727106 T AT05727106 T AT 05727106T AT 05727106 T AT05727106 T AT 05727106T AT E444375 T1 ATE444375 T1 AT E444375T1
Authority
AT
Austria
Prior art keywords
apoptosis
screening
accelerators
accelerating
compound capable
Prior art date
Application number
AT05727106T
Other languages
English (en)
Inventor
Akira Nakagawara
Toshifumi Ozaki
Original Assignee
Hisamitsu Pharmaceutical Co
Chiba Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co, Chiba Prefecture filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE444375T1 publication Critical patent/ATE444375T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
AT05727106T 2004-03-26 2005-03-23 Verfahren zum screening einer zur beschleunigung oder hemmung von apoptose fähigen verbindung, apoptosebeschleuniger und apoptosehemmer ATE444375T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004093266 2004-03-26
JP2004176107A JP2005304470A (ja) 2004-03-26 2004-06-14 アポトーシスを促進又は抑制する化合物をスクリーニングする方法、アポトーシス促進剤及びアポトーシス抑制剤
PCT/JP2005/005247 WO2005093082A1 (ja) 2004-03-26 2005-03-23 アポトーシスを促進又は抑制する化合物をスクリーニングする方法、アポトーシス促進剤及びアポトーシス抑制剤

Publications (1)

Publication Number Publication Date
ATE444375T1 true ATE444375T1 (de) 2009-10-15

Family

ID=35056210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05727106T ATE444375T1 (de) 2004-03-26 2005-03-23 Verfahren zum screening einer zur beschleunigung oder hemmung von apoptose fähigen verbindung, apoptosebeschleuniger und apoptosehemmer

Country Status (6)

Country Link
US (1) US7618787B2 (de)
EP (1) EP1739186B1 (de)
JP (1) JP2005304470A (de)
AT (1) ATE444375T1 (de)
DE (1) DE602005016911D1 (de)
WO (1) WO2005093082A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101376453B1 (ko) 2009-03-31 2014-03-19 제이엑스 닛코 닛세키 킨조쿠 가부시키가이샤 스퍼터링용 란타늄 타깃
ES2661369T3 (es) * 2010-10-26 2018-03-28 Friedrich-Alexander-Universität Erlangen-Nürnberg Células dendríticas manipuladas en su vía de transmisión de señales de NFkB

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003221349A (ja) * 2002-01-25 2003-08-05 Chiba Prefecture ｐ７３のアポトーシス誘導調節剤

Also Published As

Publication number Publication date
US7618787B2 (en) 2009-11-17
JP2005304470A (ja) 2005-11-04
WO2005093082A1 (ja) 2005-10-06
EP1739186A1 (de) 2007-01-03
EP1739186A4 (de) 2008-03-12
US20080032320A1 (en) 2008-02-07
DE602005016911D1 (de) 2009-11-12
EP1739186B1 (de) 2009-09-30

Similar Documents

Publication Publication Date Title
DE602005003951D1 (de) Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
ATE475419T1 (de) Verfahren zur zubereitung von lansoprazol
DE602005004786D1 (de) Perforatoranordnung und verfahren zur verbesserung der perforationstiefe
DE602006015892D1 (de) Verfahren zur Beschichtung von metallen
DE502006005802D1 (de) Verfahren zum fertigen von bohrungen
ATE474602T1 (de) Verfahren zur behandlung von hiv-infektion
DE602006012585D1 (de) Verfahren zur Förderung von Michael-additionsreaktionen
DE60117033D1 (de) Verfahren zur hydrocyanierung von äthylenisch ungesättigten organischen verbindungen
DE50303241D1 (de) Verfahren zur bereitstellung von abwesenheitsinformation
DE602005015590D1 (de) Verfahren zur durchführung von arbeiten auf einem teil
DE50206295D1 (de) Verfahren zur Aufbereitung von Industrieabwässern
ATE463162T1 (de) Verfahren zur verstärkung der wirksamkeit von ethaboxam
DE602005010046D1 (de) Verfahren zur verarbeitung von holzmaterial
DE602006010858D1 (de) Verfahren zur handhabung sperrenbedingter inkonsistenzen
ATE444375T1 (de) Verfahren zum screening einer zur beschleunigung oder hemmung von apoptose fähigen verbindung, apoptosebeschleuniger und apoptosehemmer
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
ATE356670T1 (de) Verfahren zur aufbereitung von sulfidmineralien
DE502005002108D1 (de) Verfahren zur funktionalisierung von biosensor-chips
DE112005002656A5 (de) Verfahren zum verzugsarmen Einsatzhärten von metallischen Bauteilen
DE502004010329D1 (de) Verfahren zur quantitativen grössenbestimmung eines weichzonenbereiches eines teilgehärteten werkstückes
ATE535506T1 (de) Verfahren zur vorbereitung von adapelen und ähnlichen verbindungen
DE60232988D1 (de) Verfahren zur alkoxylierung von organischen verbindungen
DE602004011800D1 (de) Verfahren zur Bestimmung des lokalen Emissionsprofils von suprathermischen Elektronen
DE60226772D1 (de) Verfahren zur verbesserung von phasenverschiebungsmasken
ATE335023T1 (de) Verfahren zur funktionalisierung von polyolefinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties